Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00HXZ
|
||||
Former ID |
DNC005976
|
||||
Drug Name |
2-morpholino-6-(thianthren-1-yl)-4H-chromen-4-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527888] | ||
Structure |
Download2D MOL |
||||
Formula |
C25H19NO3S2
|
||||
Canonical SMILES |
C1COCCN1C2=CC(=O)C3=C(O2)C=CC(=C3)C4=C5C(=CC=C4)SC6=CC=<br />CC=C6S5
|
||||
InChI |
1S/C25H19NO3S2/c27-19-15-24(26-10-12-28-13-11-26)29-20-9-8-16(14-18(19)20)17-4-3-7-23-25(17)31-22-6-2-1-5-21(22)30-23/h1-9,14-15H,10-13H2
|
||||
InChIKey |
NXGBJPCXFKHQKN-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | DNA-dependent protein kinase catalytic subunit | Target Info | Inhibitor | [527888] | |
KEGG Pathway | Non-homologous end-joining | ||||
Cell cycle | |||||
NetPath Pathway | IL1 Signaling Pathway | ||||
Reactome | Nonhomologous End-Joining (NHEJ) | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.